Use of the polymerase chain reaction for the detection of CBF beta/MYH11 fusion transcripts in patients with acute myeloid leukemia.

被引:0
作者
Schmohl, D [1 ]
Dohner, H [1 ]
Fischer, K [1 ]
Schlenk, R [1 ]
Haas, R [1 ]
Moos, M [1 ]
机构
[1] UNIV HEIDELBERG,DEPT INTERNAL MED 5,D-69115 HEIDELBERG,GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3101 / 3101
页数:1
相关论文
共 50 条
[31]   High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia - A single center study [J].
Mitterbauer, M ;
Laczika, K ;
Novak, M ;
Mitterbauer, G ;
Hilgarth, B ;
Pirc-Danoewinata, H ;
Schwarzinger, I ;
Haas, OA ;
Fonatsch, C ;
Lechner, K ;
Jaeger, U .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (03) :406-410
[32]   Two more inv(16) acute myeloid leukemia cases with infrequent CBFβ-MYH11 fusion transcript:: clinical and molecular findings [J].
Martinelli, G ;
Ottaviani, E ;
Buonamici, S ;
Isidori, A ;
Malagola, M ;
Piccaluga, P ;
Baccarani, M .
HAEMATOLOGICA, 2002, 87 (05) :554-555
[33]   Cytogenetically cryptic rearrangements of AML1/ETO and CBFB/MYH11 in acute myeloid leukemia. [J].
Bown, NP ;
Rowe, D ;
Cotterill, SJ ;
Ross, FM ;
Bunyan, DJ ;
Vickers, SJ ;
Bryon, J ;
McMullan, DJ ;
Griffiths, MJ ;
Watmore, A ;
Reilly, JT ;
Vandenberghe, EA ;
Wilson, G .
BLOOD, 2000, 96 (11) :187B-187B
[34]   A case of acute myeloid leukemia with inv(16)(p13q22) reveals a novel MYH11 breakpoint and a new CBFβ-MYH11 transcript variant [J].
Rowe, David ;
Strain, Lisa ;
Lowe, Chris ;
Jones, Gail .
HAEMATOLOGICA, 2007, 92 (10) :1433-1434
[35]   The Mutatome of CBFB/MYH11 Rearranged Acute Myeloid Leukemia (AML) [J].
Opatz, S. ;
Metzeler, K. H. ;
Herold, T. ;
Vosberg, S. ;
Braeundl, K. ;
Ksienzyk, B. ;
Graf, A. ;
Krebs, S. ;
Blum, H. ;
Schneider, S. ;
Konstandin, N. ;
Hiddemann, W. ;
Spiekermann, K. ;
Bohlander, S. K. ;
Greif, P. A. .
ANNALS OF HEMATOLOGY, 2015, 94 :S81-S81
[36]   Defining the ''absence'' of the CBF beta/MYH11 fusion transcript in patients with acute myeloid leukemia and inversion of chromosome 16 to predict long-term complete remission: A call for definitions [J].
Marcucci, G ;
Caligiuri, MA ;
Bloomfield, CD .
BLOOD, 1997, 90 (12) :5022-5024
[37]   Competitive CBFβ/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16):: A pilot study [J].
Laczika, K ;
Novak, M ;
Hilgarth, B ;
Mitterbauer, M ;
Mitterbauer, G ;
Scheidel-Petrovic, A ;
Scholten, C ;
Thalhammer-Scherrer, R ;
Brugger, S ;
Keil, F ;
Schwarzinger, I ;
Haas, OA ;
Lechner, K ;
Jaeger, U .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1519-1525
[38]   Detection of CBF beta/MYH11 fusion transcript: Value of minimal residual disease follow-up [J].
Costello, R ;
Cusenier, A ;
Sainty, D ;
Mozziconacci, MJ ;
Arnoulet, C ;
Blaise, D ;
Novakovitch, G ;
Maraninchi, D ;
Gastaut, JA ;
LafagePochitaloff, M ;
Gabert, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 :825-825
[39]   The Mutatome of CBFB/MYH11 Rearranged Acute Myeloid Leukemia (AML) [J].
Opatz, S. ;
Metzeler, K. H. ;
Herold, T. ;
Vosberg, S. ;
Braeundl, K. ;
Ksienzyk, B. ;
Graf, A. ;
Krebs, S. ;
Blum, H. ;
Schneider, S. ;
Konstandin, N. ;
Hiddemann, W. ;
Spiekermann, K. ;
Bohlander, S. K. ;
Greif, P. A. .
ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) :81-81
[40]   A unique structural abnormality of chromosome 16 resulting in a CBFβ-MYH11 fusion transcript in a patient with acute myeloid leukemia, FAB M4 [J].
O'Reilly, J ;
Chipper, L ;
Springall, F ;
Herrmann, R .
CANCER GENETICS AND CYTOGENETICS, 2000, 121 (01) :52-55